CIRCULITE® SYNERGY® POCKET MICRO-PUMP TO BE FEATURED AT THE INTERNATIONAL SOCIETY FOR HEART AND LUNG TRANSPLANTATION 2010

SADDLE BROOK, N.J. (April 13, 2010) – CircuLite®, Inc. will be participating at the International Society for Heart and Lung Transplantation 30th Anniversary Meeting and Scientific Sessions being held April 21 – 24, 2010 in Chicago, Illinois with a booth featuring it’s Synergy® Pocket Micro-pump. Synergy is the first micro-pump designed for long-term, partial circulatory support to improve the quality of life for a broad range of chronic heart failure patients.

CircuLite’s abstract will be displayed as a poster, #565, titled “Less Invasive Surgery with CircuLite Synergy Pocket Micro-Pump Reduces Adverse Events Versus Traditional VADs”, in the Southwest Exhibit Hall from April 21 – 23, 2010. Dr. Filip Rega will be available to answer questions near the poster during the Exhibit Hall Opening Ceremony on Wednesday, April 21, 2010 from 6:45pm – 7:45pm.

A company representative will be available at booth #610 to demonstrate and answer questions about the Synergy technology.

Receive the latest updates from the ongoing CE Mark trial for Synergy
Meet a member from CircuLite’s management team

Should you wish to meet with a representative from CircuLite at the meeting, please contact Lisa Berardo at +1 551 404-1565 or lberardo@circulite.net.

About Synergy®
The Synergy® Pocket Micro-pump represents a new approach to mechanical circulatory support that can transform chronic heart failure management by providing a less-invasive, elective treatment option for patients before their disease state becomes emergent. Synergy is the first implantable system designed to provide partial circulatory support (PCS) for long-term use in millions of unserved patients that have NYHA Class IIIb/early IV disease.

CircuLite’s patented micro-pump provides up to 3L/min of flow, which increases total cardiac output, offloads the heart, allowing it to rest, and potentially enables beneficial recovery of heart function. The size of a AA battery, the device is small enough to be implanted subcutaneously in a “pacemaker-like” pocket through a minimally-invasive procedure.

About CircuLite®
CircuLite is transforming heart failure treatment with the development of minimally-invasive devices for long-term partial circulatory support (PCS). By enabling a proactive and lower-risk treatment approach by supplementing a patient’s native pumping capacity, CircuLite has the potential to improve the quality of life for millions of chronic heart failure patients and their families. CircuLite’s pipeline of PCS devices is lead by the Synergy® Pocket Micro-pump, the world’s smallest implantable blood pump currently in a CE Mark clinical trial. Next-generation Synergy micro-pumps include an endovascular system, a fully-implantable system and a pediatric system. For more information on CircuLite and the Synergy Pocket Micro-pump devices, visit our website at www.CircuLite.net.